COSMOS Pharmaceutical Corporation

TSE:3349 Stock Report

Market Cap: JP¥557.3b

COSMOS Pharmaceutical Valuation

Is 3349 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 3349 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 3349 (¥6947) is trading below our estimate of fair value (¥20995.79)

Significantly Below Fair Value: 3349 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 3349?

Key metric: As 3349 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 3349. This is calculated by dividing 3349's market cap by their current earnings.
What is 3349's PE Ratio?
PE Ratio21.1x
EarningsJP¥26.09b
Market CapJP¥557.26b

Price to Earnings Ratio vs Peers

How does 3349's PE Ratio compare to its peers?

The above table shows the PE ratio for 3349 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average16.7x
7649 Sugi HoldingsLtd
19x6.8%JP¥470.1b
3141 Welcia Holdings
17.8x7.3%JP¥393.7b
9989 SundrugLtd
13.9x5.7%JP¥408.9b
3391 Tsuruha Holdings
16.2x8.5%JP¥401.8b
3349 COSMOS Pharmaceutical
21.1x5.9%JP¥557.3b

Price-To-Earnings vs Peers: 3349 is expensive based on its Price-To-Earnings Ratio (21.1x) compared to the peer average (16.7x).

Price to Earnings Ratio vs Industry

How does 3349's PE Ratio compare vs other companies in the JP Consumer Retailing Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
3349 21.1xIndustry Avg. 12.7xNo. of Companies16PE0816243240+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 3349 is expensive based on its Price-To-Earnings Ratio (21.1x) compared to the JP Consumer Retailing industry average (12.7x).

Price to Earnings Ratio vs Fair Ratio

What is 3349's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

3349 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio21.1x
Fair PE Ratio18.5x

Price-To-Earnings vs Fair Ratio: 3349 is expensive based on its Price-To-Earnings Ratio (21.1x) compared to the estimated Fair Price-To-Earnings Ratio (18.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 3349 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentJP¥6,947.00
JP¥8,222.86
+18.4%
12.9%JP¥10,000.00JP¥6,650.00n/a14
Nov ’25JP¥7,125.00
JP¥8,187.14
+14.9%
13.0%JP¥10,000.00JP¥6,650.00n/a14
Oct ’25JP¥7,348.00
JP¥7,660.38
+4.3%
22.4%JP¥9,750.00JP¥3,325.00n/a13
Sep ’25JP¥7,140.00
JP¥7,553.85
+5.8%
23.1%JP¥9,750.00JP¥3,325.00n/a13
Aug ’25JP¥6,910.00
JP¥7,918.75
+14.6%
16.6%JP¥9,750.00JP¥5,600.00n/a12
Jul ’25JP¥6,475.00
JP¥7,942.08
+22.7%
15.8%JP¥9,500.00JP¥5,600.00n/a12
Jun ’25JP¥6,345.00
JP¥8,260.00
+30.2%
13.6%JP¥10,000.00JP¥6,500.00n/a12
May ’25JP¥7,282.50
JP¥8,301.67
+14.0%
12.8%JP¥10,000.00JP¥6,550.00n/a12
Apr ’25JP¥6,950.00
JP¥8,309.58
+19.6%
12.4%JP¥10,000.00JP¥6,550.00n/a12
Mar ’25JP¥7,242.50
JP¥8,460.45
+16.8%
11.8%JP¥10,000.00JP¥6,550.00n/a11
Feb ’25JP¥7,980.00
JP¥8,505.42
+6.6%
11.3%JP¥10,000.00JP¥6,550.00n/a12
Jan ’25JP¥8,142.50
JP¥8,447.50
+3.7%
11.5%JP¥10,000.00JP¥6,550.00n/a12
Dec ’24JP¥7,907.50
JP¥8,266.82
+4.5%
10.8%JP¥9,500.00JP¥6,550.00n/a11
Nov ’24JP¥7,820.00
JP¥8,266.82
+5.7%
10.8%JP¥9,500.00JP¥6,550.00JP¥7,125.0011
Oct ’24JP¥7,647.50
JP¥8,370.00
+9.4%
11.2%JP¥9,500.00JP¥6,550.00JP¥7,348.0010
Sep ’24JP¥8,567.50
JP¥7,875.00
-8.1%
11.1%JP¥9,000.00JP¥6,550.00JP¥7,140.0012
Aug ’24JP¥8,242.50
JP¥7,875.00
-4.5%
11.1%JP¥9,000.00JP¥6,550.00JP¥6,910.0012
Jul ’24JP¥7,285.00
JP¥7,531.82
+3.4%
10.5%JP¥9,000.00JP¥6,250.00JP¥6,475.0011
Jun ’24JP¥6,770.00
JP¥7,381.82
+9.0%
10.9%JP¥9,000.00JP¥6,250.00JP¥6,345.0011
May ’24JP¥6,845.00
JP¥7,240.91
+5.8%
11.4%JP¥9,000.00JP¥6,250.00JP¥7,282.5011
Apr ’24JP¥5,960.00
JP¥7,359.09
+23.5%
11.7%JP¥9,500.00JP¥6,500.00JP¥6,950.0011
Mar ’24JP¥6,080.00
JP¥7,631.82
+25.5%
12.0%JP¥9,500.00JP¥6,500.00JP¥7,242.5011
Feb ’24JP¥6,375.00
JP¥7,727.27
+21.2%
11.2%JP¥9,500.00JP¥6,500.00JP¥7,980.0011
Jan ’24JP¥6,670.00
JP¥7,981.82
+19.7%
11.6%JP¥9,500.00JP¥6,500.00JP¥8,142.5011
Dec ’23JP¥7,035.00
JP¥7,972.73
+13.3%
11.1%JP¥9,500.00JP¥6,500.00JP¥7,907.5011
Nov ’23JP¥7,145.00
JP¥7,972.73
+11.6%
11.1%JP¥9,500.00JP¥6,500.00JP¥7,820.0011

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y